SCHEMBL17155155

SCHEMBL17155155

CCc1ccc(Cl)cc1/C=C/CN

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.34
IDO1 P14902 4/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SLC6A4 P31645 3/20 0.33
HTR2A P28223 2/20 0.33
MAPK1 P28482 2/20 0.33
LMNA P02545 1/20 0.33
NLRP1 Q9C000 1/20 0.33
TBXA2R P21731 1/20 0.33
PTGFR P43088 1/20 0.33
PTGER3 P43115 1/20 0.33
PTGER2 P43116 1/20 0.33
PTGIR P43119 1/20 0.33
PTGDR Q13258 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
KCNH2 Q12809 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17154235 0.82 PNMT (0.33) IDO1SLC6A4HTR2ALMNASLC6A2
SCHEMBL14904818 0.79 CYP3A4 (0.44) ERN1IDO1HPGDTSHRSLC6A4
SCHEMBL13264182 0.78 ERN1 (0.34) ERN1IDO1HPGDTSHRMEN1
SCHEMBL9176653 0.77 AHR (0.47) HPGDALDH1A1POLBCYP1A2CYP2C9
SCHEMBL17429171 0.76 ERN1 (0.53) ERN1IDO1HPGDTSHRSLC6A4
SCHEMBL16154966 0.75 LMNA (0.41) ERN1HPGDTSHRMEN1KMT2A
SCHEMBL16955178 0.74 ERN1 (0.38) ERN1IDO1HPGDTSHRMEN1
SCHEMBL16958040 0.74 ERN1 (0.42) ERN1IDO1HPGDTSHRMEN1
SCHEMBL17155197 0.74 PTGER3 (0.37) TBXA2RPTGER3PTGER2PTGDRTAAR1
SCHEMBL20040509 0.71 TAAR1 (0.46) HTR2ATAAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9388179-B2 N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels MERCK SHARP & DOHME CORP. (US) 2016-07-12 US disclosed
US-20150284389-A1 N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284389-A1 N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS SCN1B, SCN1A, SCN2B ERN1 2414/4885IDO1 2010/4885HPGD 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.